185 related articles for article (PubMed ID: 33432319)
1. Eosinophilic heart disease: diagnostic and prognostic assessment by cardiac magnetic resonance.
Antonopoulos AS; Azzu A; Androulakis E; Tanking C; Papagkikas P; Mohiaddin RH
Eur Heart J Cardiovasc Imaging; 2021 Oct; 22(11):1273-1284. PubMed ID: 33432319
[TBL] [Abstract][Full Text] [Related]
2. The Combined Incremental Prognostic Value of LVEF, Late Gadolinium Enhancement, and Global Circumferential Strain Assessed by CMR.
Mordi I; Bezerra H; Carrick D; Tzemos N
JACC Cardiovasc Imaging; 2015 May; 8(5):540-549. PubMed ID: 25890580
[TBL] [Abstract][Full Text] [Related]
3. Prognosis evaluation of chronic inflammatory cardiomyopathy with ring-like late gadolinium enhancement.
Wang H; Bo K; Gao Y; Zhou Z; Xu L
ESC Heart Fail; 2023 Jun; 10(3):1735-1744. PubMed ID: 36843322
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and Prognostic Value of Cardiovascular Magnetic Resonance in Neuromuscular Cardiomyopathies.
Almogheer B; Antonopoulos AS; Azzu A; Al Mohdar S; Vlachopoulos C; Pantazis A; Mohiaddin RH
Pediatr Cardiol; 2022 Jan; 43(1):27-38. PubMed ID: 34342696
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging of dilated cardiomyopathy: prognostic benefit of identifying late gadolinium enhancement in Asian patients.
Infante AN; Koo CCY; Yip A; Lim YH; Yeo WT; Quek ST; Lim TW; Seow SC; Chai P; Ong CC; Teo L; Singh D; Kojodjojo P
Singapore Med J; 2021 Jul; 62(7):347-352. PubMed ID: 31820004
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular Magnetic Resonance Imaging Phenotypes and Long-term Outcomes in Patients With Suspected Cardiac Sarcoidosis.
Athwal PSS; Chhikara S; Ismail MF; Ismail K; Ogugua FM; Kazmirczak F; Bawaskar PH; Elton AC; Markowitz J; von Wald L; Roukoz H; Bhargava M; Perlman D; Shenoy C
JAMA Cardiol; 2022 Oct; 7(10):1057-1066. PubMed ID: 36103165
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and prognostic value of right ventricular (dys)function in patients with non-ischaemic dilated cardiomyopathy assessed with cardiac magnetic resonance imaging.
Becker MAJ; van der Lingen ACJ; Wubben M; van de Ven PM; van Rossum AC; Cornel JH; Allaart CP; Germans T
ESC Heart Fail; 2021 Apr; 8(2):1055-1063. PubMed ID: 33560582
[TBL] [Abstract][Full Text] [Related]
8. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy.
Wu KC; Weiss RG; Thiemann DR; Kitagawa K; Schmidt A; Dalal D; Lai S; Bluemke DA; Gerstenblith G; Marbán E; Tomaselli GF; Lima JA
J Am Coll Cardiol; 2008 Jun; 51(25):2414-21. PubMed ID: 18565399
[TBL] [Abstract][Full Text] [Related]
9. Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study.
Pöyhönen P; Kivistö S; Holmström M; Hänninen H
BMC Cardiovasc Disord; 2014 Aug; 14():110. PubMed ID: 25160650
[TBL] [Abstract][Full Text] [Related]
10. Complexity of scar and ventricular arrhythmias in dilated cardiomyopathy of any etiology: Long-term data from the SCARFEAR (Cardiovascular Magnetic Resonance Predictors of Appropriate Implantable Cardioverter-Defibrillator Therapy Delivery) Registry.
Pedretti S; Vargiu S; Baroni M; Dellegrottaglie S; Lanzarin B; Roghi A; Milazzo A; Quattrocchi G; Lunati M; Pedrotti P
Clin Cardiol; 2018 Apr; 41(4):494-501. PubMed ID: 29663442
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.
Pontone G; Guaricci AI; Andreini D; Solbiati A; Guglielmo M; Mushtaq S; Baggiano A; Beltrama V; Fusini L; Rota C; Segurini C; Conte E; Gripari P; Dello Russo A; Moltrasio M; Tundo F; Lombardi F; Muscogiuri G; Lorenzoni V; Tondo C; Agostoni P; Bartorelli AL; Pepi M
Circ Cardiovasc Imaging; 2016 Oct; 9(10):. PubMed ID: 27729359
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of late gadolinium enhancement in cardiac MRI of non-ischemic dilated cardiomyopathy patients.
Behera DR; V K AK; K K NN; S S; Nair KKM; G S; T R K; Gopalakrishnan A; S H
Indian Heart J; 2020; 72(5):362-368. PubMed ID: 33189195
[TBL] [Abstract][Full Text] [Related]
13. Subendocardial Involvement as an Underrecognized LGE Subtype Related to Adverse Outcomes in Hypertrophic Cardiomyopathy.
Yang S; Zhao K; Yang K; Song J; Yu S; Wang J; Dong Z; Ma X; Yin G; Li J; Cheng H; Lu M; Chen X; Zhao S
JACC Cardiovasc Imaging; 2023 Sep; 16(9):1163-1177. PubMed ID: 37204388
[TBL] [Abstract][Full Text] [Related]
14. Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy.
Barison A; Aimo A; Ortalda A; Todiere G; Grigoratos C; Passino C; Camici PG; Aquaro GD; Emdin M
Int J Cardiol; 2018 Jan; 250():195-200. PubMed ID: 29107357
[TBL] [Abstract][Full Text] [Related]
15. Cardiac magnetic resonance in histologically proven eosinophilic myocarditis.
Pöyhönen P; Rågback J; Mäyränpää MI; Nordenswan HK; Lehtonen J; Shenoy C; Kupari M
J Cardiovasc Magn Reson; 2023 Dec; 25(1):79. PubMed ID: 38105221
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Late Gadolinium Enhancement Detected on Cardiac Magnetic Resonance in Cardiac Sarcoidosis.
Stevenson A; Bray JJH; Tregidgo L; Ahmad M; Sharma A; Ng A; Siddiqui A; Khalid AA; Hylton K; Ionescu A; Providencia R; Kirresh A
JACC Cardiovasc Imaging; 2023 Mar; 16(3):345-357. PubMed ID: 36752432
[TBL] [Abstract][Full Text] [Related]
17. Conductive channels identified with contrast-enhanced MR imaging predict ventricular tachycardia in systolic heart failure.
Lin LY; Su MY; Chen JJ; Lai LP; Hwang JJ; Tseng CD; Chen YS; Yu HY; Tseng WY; Lin JL
JACC Cardiovasc Imaging; 2013 Nov; 6(11):1152-9. PubMed ID: 24229767
[TBL] [Abstract][Full Text] [Related]
18. Long-term prognostic value of vasodilator stress cardiac magnetic resonance in patients with atrial fibrillation.
Weiss KJ; Nasser SB; Bigvava T; Doltra A; Schnackenburg B; Berger A; Anker MS; Stehning C; Doeblin P; Abdelmeguid M; Talat M; Gebker R; E-Naggar W; Pieske B; Kelle S
ESC Heart Fail; 2022 Feb; 9(1):110-121. PubMed ID: 34866358
[TBL] [Abstract][Full Text] [Related]
19. The Extent of Late Gadolinium Enhancement Can Predict Adverse Cardiac Outcomes in Patients with Non-Ischemic Cardiomyopathy with Reduced Left Ventricular Ejection Fraction: A Prospective Observational Study.
Kim EK; Lee GY; Jang SY; Chang SA; Kim SM; Park SJ; Choi JO; Park SW; Choe YH; Lee SC; Oh JK
Korean J Radiol; 2021 Mar; 22(3):324-333. PubMed ID: 32932562
[TBL] [Abstract][Full Text] [Related]
20. The combination of carboxy-terminal propeptide of procollagen type I blood levels and late gadolinium enhancement at cardiac magnetic resonance provides additional prognostic information in idiopathic dilated cardiomyopathy - A multilevel assessment of myocardial fibrosis in dilated cardiomyopathy.
Raafs AG; Verdonschot JAJ; Henkens MTHM; Adriaans BP; Wang P; Derks K; Abdul Hamid MA; Knackstedt C; van Empel VPM; Díez J; Brunner-La Rocca HP; Brunner HG; González A; Bekkers SCAM; Heymans SRB; Hazebroek MR
Eur J Heart Fail; 2021 Jun; 23(6):933-944. PubMed ID: 33928704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
